2024-04-012025-03-312025-03-31false13286246MILNER DENTAL CARE LTD2025-08-27falseiso4217:GBPxbrli:pure132862462024-03-31132862462025-03-31132862462024-04-012025-03-31132862462023-03-31132862462024-03-31132862462023-04-012024-03-3113286246bus:SmallEntities2024-04-012025-03-3113286246bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3113286246bus:FullAccounts2024-04-012025-03-3113286246bus:PrivateLimitedCompanyLtd2024-04-012025-03-3113286246core:WithinOneYear2025-03-3113286246core:AfterOneYear2025-03-3113286246core:WithinOneYear2024-03-3113286246core:AfterOneYear2024-03-3113286246core:ShareCapital2025-03-3113286246core:SharePremium2025-03-3113286246core:RevaluationReserve2025-03-3113286246core:OtherReservesSubtotal2025-03-3113286246core:RetainedEarningsAccumulatedLosses2025-03-3113286246core:ShareCapital2024-03-3113286246core:SharePremium2024-03-3113286246core:RevaluationReserve2024-03-3113286246core:OtherReservesSubtotal2024-03-3113286246core:RetainedEarningsAccumulatedLosses2024-03-3113286246core:LandBuildings2025-03-3113286246core:PlantMachinery2025-03-3113286246core:Vehicles2025-03-3113286246core:FurnitureFittings2025-03-3113286246core:OfficeEquipment2025-03-3113286246core:NetGoodwill2025-03-3113286246core:IntangibleAssetsOtherThanGoodwill2025-03-3113286246core:ListedExchangeTraded2025-03-3113286246core:UnlistedNon-exchangeTraded2025-03-3113286246core:LandBuildings2024-03-3113286246core:PlantMachinery2024-03-3113286246core:Vehicles2024-03-3113286246core:FurnitureFittings2024-03-3113286246core:OfficeEquipment2024-03-3113286246core:NetGoodwill2024-03-3113286246core:IntangibleAssetsOtherThanGoodwill2024-03-3113286246core:ListedExchangeTraded2024-03-3113286246core:UnlistedNon-exchangeTraded2024-03-3113286246core:LandBuildings2024-04-012025-03-3113286246core:PlantMachinery2024-04-012025-03-3113286246core:Vehicles2024-04-012025-03-3113286246core:FurnitureFittings2024-04-012025-03-3113286246core:OfficeEquipment2024-04-012025-03-3113286246core:NetGoodwill2024-04-012025-03-3113286246core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3113286246core:ListedExchangeTraded2024-04-012025-03-3113286246core:UnlistedNon-exchangeTraded2024-04-012025-03-3113286246core:MoreThanFiveYears2024-04-012025-03-3113286246core:Non-currentFinancialInstruments2025-03-3113286246core:Non-currentFinancialInstruments2024-03-3113286246dpl:CostSales2024-04-012025-03-3113286246dpl:DistributionCosts2024-04-012025-03-3113286246core:LandBuildings2024-04-012025-03-3113286246core:PlantMachinery2024-04-012025-03-3113286246core:Vehicles2024-04-012025-03-3113286246core:FurnitureFittings2024-04-012025-03-3113286246core:OfficeEquipment2024-04-012025-03-3113286246dpl:AdministrativeExpenses2024-04-012025-03-3113286246core:NetGoodwill2024-04-012025-03-3113286246core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3113286246dpl:GroupUndertakings2024-04-012025-03-3113286246dpl:ParticipatingInterests2024-04-012025-03-3113286246dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3113286246core:ListedExchangeTraded2024-04-012025-03-3113286246dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3113286246core:UnlistedNon-exchangeTraded2024-04-012025-03-3113286246dpl:CostSales2023-04-012024-03-3113286246dpl:DistributionCosts2023-04-012024-03-3113286246core:LandBuildings2023-04-012024-03-3113286246core:PlantMachinery2023-04-012024-03-3113286246core:Vehicles2023-04-012024-03-3113286246core:FurnitureFittings2023-04-012024-03-3113286246core:OfficeEquipment2023-04-012024-03-3113286246dpl:AdministrativeExpenses2023-04-012024-03-3113286246core:NetGoodwill2023-04-012024-03-3113286246core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3113286246dpl:GroupUndertakings2023-04-012024-03-3113286246dpl:ParticipatingInterests2023-04-012024-03-3113286246dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3113286246core:ListedExchangeTraded2023-04-012024-03-3113286246dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3113286246core:UnlistedNon-exchangeTraded2023-04-012024-03-3113286246core:NetGoodwill2025-03-3113286246core:IntangibleAssetsOtherThanGoodwill2025-03-3113286246core:LandBuildings2025-03-3113286246core:PlantMachinery2025-03-3113286246core:Vehicles2025-03-3113286246core:FurnitureFittings2025-03-3113286246core:OfficeEquipment2025-03-3113286246core:AfterOneYear2025-03-3113286246core:WithinOneYear2025-03-3113286246core:ListedExchangeTraded2025-03-3113286246core:UnlistedNon-exchangeTraded2025-03-3113286246core:ShareCapital2025-03-3113286246core:SharePremium2025-03-3113286246core:RevaluationReserve2025-03-3113286246core:OtherReservesSubtotal2025-03-3113286246core:RetainedEarningsAccumulatedLosses2025-03-3113286246core:NetGoodwill2024-03-3113286246core:IntangibleAssetsOtherThanGoodwill2024-03-3113286246core:LandBuildings2024-03-3113286246core:PlantMachinery2024-03-3113286246core:Vehicles2024-03-3113286246core:FurnitureFittings2024-03-3113286246core:OfficeEquipment2024-03-3113286246core:AfterOneYear2024-03-3113286246core:WithinOneYear2024-03-3113286246core:ListedExchangeTraded2024-03-3113286246core:UnlistedNon-exchangeTraded2024-03-3113286246core:ShareCapital2024-03-3113286246core:SharePremium2024-03-3113286246core:RevaluationReserve2024-03-3113286246core:OtherReservesSubtotal2024-03-3113286246core:RetainedEarningsAccumulatedLosses2024-03-3113286246core:NetGoodwill2023-03-3113286246core:IntangibleAssetsOtherThanGoodwill2023-03-3113286246core:LandBuildings2023-03-3113286246core:PlantMachinery2023-03-3113286246core:Vehicles2023-03-3113286246core:FurnitureFittings2023-03-3113286246core:OfficeEquipment2023-03-3113286246core:AfterOneYear2023-03-3113286246core:WithinOneYear2023-03-3113286246core:ListedExchangeTraded2023-03-3113286246core:UnlistedNon-exchangeTraded2023-03-3113286246core:ShareCapital2023-03-3113286246core:SharePremium2023-03-3113286246core:RevaluationReserve2023-03-3113286246core:OtherReservesSubtotal2023-03-3113286246core:RetainedEarningsAccumulatedLosses2023-03-3113286246core:AfterOneYear2024-04-012025-03-3113286246core:WithinOneYear2024-04-012025-03-3113286246core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3113286246core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3113286246core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3113286246core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3113286246core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3113286246core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3113286246core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3113286246core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3113286246core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3113286246core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3113286246core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3113286246core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3113286246core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3113286246core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3113286246core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3113286246core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3113286246core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3113286246core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3113286246core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3113286246core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3113286246core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3113286246core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3113286246core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3113286246core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3113286246core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3113286246core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3113286246core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3113286246bus:Director12024-04-012025-03-31

MILNER DENTAL CARE LTD

Registered Number
13286246
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

MILNER DENTAL CARE LTD
Company Information
for the year from 1 April 2024 to 31 March 2025

Director

Dr Natalie Milner

Registered Address

918 Middleton Road
Chadderton
Oldham
OL9 9SB

Registered Number

13286246 (England and Wales)
MILNER DENTAL CARE LTD
Statement of Financial Position
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets3447,100447,100
Tangible assets4304,947264,612
752,047711,712
Current assets
Stocks514,30011,000
Debtors115,06277,879
Cash at bank and on hand106,54986,862
235,911175,741
Creditors amounts falling due within one year6(69,070)(93,447)
Net current assets (liabilities)166,84182,294
Total assets less current liabilities918,888794,006
Creditors amounts falling due after one year7(445,540)(465,006)
Provisions for liabilities8(20,870)(14,814)
Net assets452,478314,186
Capital and reserves
Called up share capital11
Profit and loss account452,477314,185
Shareholders' funds452,478314,186
The financial statements were approved and authorised for issue by the Director on 27 August 2025, and are signed on its behalf by:
Dr Natalie Milner
Director
Registered Company No. 13286246
MILNER DENTAL CARE LTD
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling, which is the functional currency of the entity.
Going concern
The UK economy has recently been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company's trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.
Judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. These critical accounting judgements and estimations are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The critical judgements made by management that have a significant effect on the amounts recognised in the financial statements are described below.
Turnover policy
The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year end date is recognised by reference to the state of completion.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
Deferred tax
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted, or substantively enacted, by the reporting date that are expected to apply to the reversal of the timing difference.
Intangible assets
Goodwill arises on business acquisitions and represents the excess of the cost of the acquisition over the company's interest in the net amount of the identifiable assets, liabilities and contingent liabilities of the acquired business. Goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. It is amortised on a straight-line basis over its useful life. Where a reliable estimate of the useful life of goodwill or intangible assets cannot be made, the life is presumed not to exceed ten years.
Tangible fixed assets and depreciation
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Reducing balance (%)
Plant and machinery20
Vehicles20
Office Equipment20
Stocks and work in progress
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all cost of purchase, cost of conversion and other costs incurred in bringing the stock to its present location and condition.
2.Average number of employees

20252024
Average number of employees during the year66
3.Intangible assets

Other

Total

££
Cost or valuation
At 01 April 24447,100447,100
At 31 March 25447,100447,100
Net book value
At 31 March 25447,100447,100
At 31 March 24447,100447,100
4.Tangible fixed assets

Land & buildings

Plant & machinery

Vehicles

Office Equipment

Total

£££££
Cost or valuation
At 01 April 24186,65344,217-61,645292,515
Additions-34,11135,15062069,881
At 31 March 25186,65378,32835,15062,265362,396
Depreciation and impairment
At 01 April 24-14,324-13,57927,903
Charge for year-12,8027,0309,71429,546
At 31 March 25-27,1267,03023,29357,449
Net book value
At 31 March 25186,65351,20228,12038,972304,947
At 31 March 24186,65329,893-48,066264,612
5.Stocks

2025

2024

££
Raw materials and consumables14,30011,000
Total14,30011,000
6.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables6,7196,503
Bank borrowings and overdrafts-37,483
Taxation and social security44,39326,070
Other creditors14,92420,392
Accrued liabilities and deferred income3,0342,999
Total69,07093,447
7.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts445,540465,006
Total445,540465,006
8.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)20,87014,814
Total20,87014,814
9.Related party transactions
During the year the director made available a loan to the company. At the year end the balance of the loan was £14,544 (2024: £20,036)